MicroRNA Therapy for Dry Eye Disease.

Chun-Huei Liao1, Ching-Li Tseng2,3, Shiun-Long Lin4

  • 1Department of Medical Research, Center for Myopia and Eye Disease, China Medical University Hospital, Taichung, Taiwan.

Summary

MicroRNA-328 (miR-328) is implicated in dry eye disease (DED). Topical anti-miR-328 eye drops effectively reduced DED signs and promoted corneal healing in animal models, suggesting a novel therapeutic approach.